This content was archived on June 24, 2013.
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
Pest Management Regulatory Agency
17 March 2011
ISSN: 1925-1025 (PDF version)
Catalogue number: H113-28/2011-2E-PDF (PDF version)
Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
After a re-evaluation of the pesticides containing thiabendazole, Health Canada's Pest Management Regulatory Agency (PMRA), under the authority of the
Pest Control Products Act and
Regulations, is granting continued registration of products containing thiabendazole for sale and use in Canada.
An evaluation of available scientific information found that products containing thiabendazole do not present unacceptable risks to human health or the environment when used according to label directions. As a condition of the continued registration of thiabendazole uses, new risk-reduction measures must be included on the labels of all products. No additional data are required at this time.
The regulatory approach for the re-evaluation of thiabendazole was first presented in Proposed Re-evaluation Decision PRVD2010-12, Thiabendazole, a consultation document.1 This Re-evaluation Decision2 describes this stage of PMRA's regulatory process for the re-evaluation of thiabendazole as well as summarizes the Agency's decision and the reasons for it. No comments were received during the consultation process. This decision is consistent with the proposed re-evaluation decision stated in PRVD2010-12. To comply with this decision, registrants of products containing thiabendazole will be informed of the specific requirements affecting their product registration(s).The PMRA's pesticide re-evaluation program considers potential risks, as well as value, of pesticide products to ensure they meet modern standards established to protect human health and the environment. Regulatory Directive DIR2001-03, PMRA Re-evaluation Program, presents the details of the re-evaluation activities and program structure.
Thiabendazole, one of the active ingredients in the current re-evaluation cycle, has been re-evaluated under Re-evaluation Program 1. This program relies as much as possible on foreign reviews, typically
United States Environmental Protection Agency (USEPA) Reregistration Eligibility Decision (RED) documents. For products to be re-evaluated under Program 1, the foreign review must meet the following conditions:
Based on the outcome of foreign reviews and a review of the chemistry of Canadian products, the PMRA has made a regulatory decision and requires appropriate risk-reduction measures for Canadian uses of thiabendazole. In this decision, the PMRA took into account the Canadian use pattern and issues (e.g. the federal
Toxic Substances Management Policy [TSMP]).
The USEPA re-evaluated thiabendazole and published its conclusions in a 2002 RED.
For more details on the information presented in this Re-evaluation Decision, please refer to the Science Evaluation in the related Proposed Re-evaluation Decision PRVD2010-12, Thiabendazole.
Thiabendazole is a fungicide that is used to control fungal diseases on fruits and vegetables. Thiabendazole is applied as a postharvest spray treatment on apples, pears, potatoes and chicory roots (intended for Belgian endive production), a drench on white button mushrooms, and as a pre-planting treatment of chickpea and lentil seed. Thiabendazole is also registered for use in control of Dutch elm disease in elm trees and as a material preservative in paints, adhesives, paper and textiles.
Thiabendazole is unlikely to affect your health when used according to the revised label directions.
People could be exposed to thiabendazole by consuming food and water, working as a mixer/loader/applicator, by entering treated sites or by handling thiabendazole-treated products. The PMRA considers two key factors when assessing health risks: the levels at which no health effects occur and the levels to which people may be exposed. The dose levels used to assess risks are established to protect the most sensitive human population (for example, children and nursing mothers). Only uses for which exposure is well below levels that cause no effects in animal testing are considered acceptable for continued registration.
The USEPA concluded that thiabendazole was unlikely to affect human health provided that risk-reduction measures were implemented. These conclusions apply to the Canadian situation, and similar risk-reduction measures are required. Additional mitigation measures are required based on risk assessments conducted by the PMRA.
The
Food and Drugs Act prohibits the sale of food containing a pesticide residue that exceeds the established maximum residue limit (MRL). Pesticide MRLs are established for Food and Drugs Act purposes through the evaluation of scientific data under the Pest Control Products Act. Each MRL value defines the maximum concentration in parts per million (ppm) of a pesticide allowed in/on certain foods. Food containing a pesticide residue that does not exceed the established MRL does not pose an unacceptable health risk.
Thiabendazole is currently registered in Canada for use on apples, pears, potato, and chicory root, white button mushrooms and on chickpea and lentil seed, and could be used in other countries on crops that are imported into Canada. The following specific MRLs have been established: apple (wet pomace) 10 ppm, pear 10 ppm, potato 10 ppm, citrus fruit 10 ppm, banana 0.4 ppm and endive (chicory roots) 0.05 ppm. Where no specific MRL has been established, a default MRL of 0.1 ppm applies, which means that pesticide residues in a food commodity must not exceed 0.1 ppm. However, changes to this general MRL may be implemented in the future, as indicated in the December 2009 Information Note, Progress on Minimizing Reliance on the 0.1 Parts per Million as a General Maximum Residue Limit for Food Pesticide Residue.
Thiabendazole is unlikely to affect non-target organisms when used according to the revised label directions.
Environmental risk is assessed by the risk quotient method - the ratio of the estimated environmental concentration to the relevant effects endpoint of concern. The resulting risk quotients are compared to corresponding levels of concern. A risk quotient less than the level of concern is considered a negligible risk to non-target organisms, whereas a risk quotient greater than the level of concern indicates some degree of risk.
The USEPA concluded that thiabendazole was unlikely to adversely affect the environment and, the reregistration of thiabendazole was acceptable. No additional mitigation measures were required by the USEPA. These conclusions apply to the Canadian situation. Based on PMRA practices, general environmental hazard label statements are required by the PMRA.
Labels of registered pesticide products include specific instructions for use. Directions include risk-reduction measures to protect human and environmental health. These directions must be followed by law. As a result of the re-evaluation of thiabendazole, the PMRA is requiring further risk-reduction measures for product labels.
Appendix I lists all required label amendments.
Any person may file a notice of objection3 regarding this decision on thiabendazole within 60 days from the date of publication of this Re-evaluation Decision. For more information regarding the basis for objecting (which must be based on scientific grounds), please refer to the Pesticides and Pest Management portion of Health Canada's website (Request a Reconsideration of Decision) or contact the PMRA's Pest Management Information Service.
The label amendments presented below do not include all label requirements for individual end-use products, such as first aid statements, disposal statements, precautionary statements and supplementary protective equipment. Information on labels of currently registered products should not be removed unless it contradicts the label statements below.
The labels of end-use products in Canada must be amended to include the following statements to further protect workers and the environment.